Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Debt-to-EBITDA : -0.94 (As of Nov. 2023)

Cannabis Bioscience International Holdings Debt-to-EBITDA Chart

Cannabis Bioscience International Holdings Semi-Annual Data
	Dec06	Jun07	Dec07	Jun08	May09	Nov09	May10	Nov10	May11	Nov11	Nov22	Nov23
Debt-to-EBITDA	Get a 7-Day Free Trial							0.17	0.35	0.22	-	-0.94

Competitive Comparison of Cannabis Bioscience International Holdings's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Bioscience International Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannabis Bioscience International Holdings's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Bioscience International Holdings's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Cannabis Bioscience International Holdings's Debt-to-EBITDA falls into.

Cannabis Bioscience International Holdings Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Cannabis Bioscience International Holdings's Debt-to-EBITDA for the fiscal year that ended in May. 2011 is calculated as

Cannabis Bioscience International Holdings's annualized Debt-to-EBITDA for the quarter that ended in Nov. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Nov. 2023) EBITDA data.

Cannabis Bioscience International Holdings  (OTCPK:CBIH) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Cannabis Bioscience International Holdings Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Cannabis Bioscience International Holdings's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Business Description